Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: a preferential benefit for squamous cell carcinoma. Radiol Oncol [Internet]. 2021 Feb. 15 [cited 2026 Jul. 28];55(1):66-7. Available from: https://www.ojstest.computing.si/index.php/ro/article/view/3516